Poziotinib in Patients With HER2+ Recurrent Stage IV BC Who Have Received at Least 2 Prior HER2-directed Regimens
Clinical trial NCT02418689 · COMPLETED
Trial details
- NCT number
- NCT02418689
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2017-06-01
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.